United States Drug Repurposing Market represents the largest share of the North American region, driven by substantial R&D expenditure, a strong presence of leading pharmaceutical and biotechnology companies, and increasing demand for faster drug approval pathways. The country has witnessed growing adoption of data-driven drug discovery platforms, genomic research, and AI-enabled...